Company

AiCuris Anti-infective Cures AG

Biotechnology Research United States 76 employees

Employees: 76
Contacts: 3
Emails: 3

www.aicuris.com LinkedIn Crunchbase

AiCuris Anti-infective Cures AG Overview

Headquarters: United States
Website: www.aicuris.com
Industry: Biotechnology Research
Employees: 76
Founded: 2006
Funding: 74.8M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Anti-infectives Virology Pre-clinical and clinical development

About AiCuris Anti-infective Cures AG

AiCuris is meeting the needs of the growing population of immunocompromised people who require precise therapies to effectively treat infection. Our flagship product, PREVYMIS, marketed by our partner MSD, treats CMV in a defined group of transplant recipients. Our pivotal phase 3 candidate Pritelivir is designed to address recurrent and resistant HSV infections in a broad population of patients with weakened immune systems. For immunocompromised people, an otherwise manageable infection can mean life or death. AiCuris, with its expertise and growing pipeline, is committed to providing therapeutic solutions for them now and in the future.

AiCuris Anti-infective Cures AG Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

AiCuris Anti-infective Cures AG Org Chart

Sample employees and titles

Name	Title	Location	Contact
Xavier Prugnard	Vice-president Regulatory Affairs at Aicuris	France	Email
Mark Stesney	Supply Chain Executive - Life Sciences - Aicuris Pharmaceuticals	Greater Boston, United States	Email
Gerrit Van Dyken			View
Dilruwan Chaminda Herath	Father - Husband - Doctor - Promethean - Intrepid - Kind - Azvasana	Greater London, England, United Kingdom	Email